Viewing Study NCT05270057


Ignite Creation Date: 2025-12-24 @ 7:03 PM
Ignite Modification Date: 2025-12-25 @ 4:36 PM
Study NCT ID: NCT05270057
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-09
First Post: 2022-02-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies
Sponsor: Medical College of Wisconsin
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module